MRMahmoud Razavian

Mahmoud Razavian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mahmoud Razavian has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Albert J. Sinusas

    Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine (M.R., S.T., J.Z., L.N., L.W.D., A.J.S., M.M.S.), Yale University School of Medicine, New Haven, CT

    2 shared publications
  • Lei Nie

    Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine (M.R., S.T., J.Z., L.N., L.W.D., A.J.S., M.M.S.), Yale University School of Medicine, New Haven, CT

    2 shared publications
  • Mehran M. Sadeghi

    Yale University School of Medicine

    2 shared publications
  • Michael Azure

    Lantheus Medical Imaging (M.A., S.R.), North Billerica, MA

    2 shared publications
  • Sina Tavakoli

    Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine (M.R., S.T., J.Z., L.N., L.W.D., A.J.S., M.M.S.), Yale University School of Medicine, New Haven, CT

    2 shared publications
  • Wawrzyniec Lawrence Dobrucki

    University of Illinois at Urbana−Champaign

    2 shared publications

Latest Publications

  • Open Access

    Atherosclerosis Plaque Heterogeneity and Response to Therapy Detected by In Vivo Molecular Imaging of Matrix Metalloproteinase Activation

    by Mahmoud Razavian, Sina Tavakoli, Jiasheng Zhang, Lei Nie, Lawrence W. Dobrucki, Albert J. Sinusas, Michael Azure, Simon Robinson, Mehran M. Sadeghi

    Matrix metalloproteinases (MMPs) play a key role in the development of atherosclerosis and its complications. In vivo detection and quantification of MMP activation can help track the propensity to complications and response to therapy. We sought to establish an in vivo imaging approach for monitoring MMP activation in atherosclerotic mouse aorta and use it to assess the response to dietary modification. Method: Apolipoprotein-deficient mice were fed normal chow or a high-fat diet (HFD) for up to 3 mo or a HFD for 2 mo, followed by 1 mo on normal chow. Then they underwent micro-SPECT/CT, along with autoradiography and oil red O staining of tissues. Results: After 3 mo of HFD, there was considerable atherosclerosis in the aorta. In vivo micro-SPECT/CT using RP782 (an 111In-labeled tracer targeting activated MMPs) showed a heterogeneous pattern of tracer uptake along the aorta. Heterogeneity of RP782 uptake was confirmed by autoradiography, and specificity was demonstrated using excess unlabeled precursor. Tracer uptake quantified by micro-SPECT significantly correlated with uptake quantified by autoradiography. Comparison of oil red O staining with autoradiography demonstrated areas of discordance between plaque presence and tracer uptake. HFD withdrawal led to significant reduction in RP782 uptake beyond the effect on plaque area. MMP expression and macrophage infiltration were similarly heterogeneous along the aorta and significantly reduced after withdrawal from the HFD. Finally, RP782 uptake significantly correlated with aortic macrophage content. Conclusion: Molecular imaging of MMP activation reveals the heterogeneity of atherosclerotic plaques and is a useful tool for tracking plaque biology and response to therapy.


  • Molecular Imaging of Matrix Metalloproteinase Activation to Predict Murine Aneurysm Expansion In Vivo

    by Mahmoud Razavian, Jiasheng Zhang, Lei Nie, Sina Tavakoli, Niema Razavian, Lawrence W. Dobrucki, Albert J. Sinusas, D. Scott Edwards, Michael Azure, Mehran M. Sadeghi

    Rupture and dissection are major causes of morbidity and mortality in arterial aneurysm and occur more frequently in rapidly expanding aneurysms. Current imaging modalities provide little information on aneurysm beyond size. Matrix metalloproteinase (MMP) activation plays a key role in the pathogenesis of aneurysm. We investigated whether imaging MMP activation in aneurysm helps predict its propensity to expansion. Methods: We used a model of carotid aneurysm in apolipoprotein E–deficient (apoE−/−) mice. Radiotracers with specificity for activated MMPs were used to detect and quantify MMP activation by micro-SPECT/CT in vivo. Tracer uptake was confirmed by autoradiography and γ-well counting, and specificity was demonstrated using an excess of unlabeled precursor and a specific MMP inhibitor. Results: We demonstrated that several MMPs are expressed with distinct temporal patterns in aneurysm. Significant focal uptake was observed in aneurysmal carotid arteries, peaking at 4 wk after aneurysm induction. In a group of animals imaged serially at 2 and 4 wk after aneurysm induction, MMP tracer uptake at 2 wk correlated well with the vessel area assessed by histology at 4 wk. Conclusion: Molecular imaging of MMP activation is a useful experimental, and potentially clinical, tool to noninvasively predict the propensity of an aneurysm to expansion in vivo.